Page 104 - 80_02
P. 104
Papel
del
tejido
adiposo
blanco,
marrón
y
perivascular…
18. Gastaldelli
A,
Miyazaki
Y,
Pettiti
M,
Matsuda
M,
Mahankali
S,
Santini
E,
et
al.
Metabolic
effects
of
visceral
fat
accumulation
in
type
2
diabetes.
J
Clin
Endocrinol
Metab.
2002;
87(11):5098--103.
19. Marin
P,
Andersson
B,
Ottosson
M,
Olbe
L,
Chowdhury
B,
Kvist
H,
et
al.
The
morphology
and
metabolism
of
intraabdominal
adipose
tissue
in
men.
Metabolism.1992;
41(11):1242--
1248.
20. Montague
CT,
Prins
JB,
Sanders
L,
Digby
JE,
O'Rahilly
S.
Depot--
and
sex--specific
differences
in
human
leptin
mRNA
expression:
implications
for
the
control
of
regional
fat
distribution.
Diabetes
1997;
46(3):342--347.
21. Wajchenberg
BL.
Subcutaneous
and
visceral
adipose
tissue:
their
relation
to
the
metabolic
syndrome.
Endocr
Rev
2000;
21(6):697--738.
22. Bjorntorp
P.
Metabolic
implications
of
body
fat
distribution.
Diabetes
Care
1991;14
(12):1132--1143.
23. Hellmer
J,
Marcus
C,
Sonnenfeld
T,
Arner
P.
Mechanisms
for
differences
in
lipolysis
between
human
subcutaneous
and
omental
fat
cells.
J
Clin
Endocrinol
Metab.
1992;
75(1):15--20.
24. Fain
JN,
Madan
AK,
Hiler
ML,
Cheema
P,
Bahouth
SW.
Comparison
of
the
release
of
adipokines
by
adipose
tissue,
adipose
tissue
matrix,
and
adipocytes
from
visceral
and
subcutaneous
abdominal
adipose
tissues
of
obese
humans.
Endocrinology
2004;
145(5):2273--2282.
25. Snijder
MB,
Dekker
JM,
Visser
M,
Bouter
LM,
Stehouwer
CD,
Kostense
PJ
et
al.
Associations
of
hip
and
thigh
circumferences
independent
of
waist
circumference
with
the
incidence
of
type
2
diabetes:
the
Hoorn
Study.
Am
J
Clin
Nutr
2003;
77(5):1192--1197.
26. Fox
CS,
Massaro
JM,
Hoffmann
U,
Pou
KM,
Maurovich--Horvat
P,
Liu
CY
et
al.
Abdominal
visceral
and
subcutaneous
adipose
tissue
compartments:
association
with
metabolic
risk
factors
in
the
Framingham
Heart
Study.
Circulation
2007;
116(1):39--48.
27. Arner
P,
Eckel
RH.
Adipose
tissue
as
storage
organ.
En:
George
A.
Bray,
Claude
Bouchard,
WPT.
James,
editors.
Handbook
of
Obesity.
1998:379--395.
28. Wang
H,
Eckel
RH.
Lipoprotein
lipase:
from
gene
to
obesity.
Am
J
Physiol
Endocrinol
Metab.
2009;
297(2):E271--88.
29. Bessesen
DH,
Robertson
AD,
Eckel
RH.
Weight
reduction
increases
adipose
but
decreases
cardiac
LPL
in
reduced--obese
Zucker
rats.
Am
J
Physiol
Endocrinol
Metab.
1991;
261(2
Pt
1):
E246–E251.
30. Eckel
RH,
Yost
TJ.
Weight
reduction
increases
adipose
tissue
lipoprotein
lipase
responsiveness
in
obese
women.
J
Clin
Invest.1987;
80(4):992–997.
31. Pollare
T,
Vessby
B,
Lithell
H.
Lipoprotein
lipase
activity
in
skeletal
muscle
is
related
to
insulin
sensitivity.
Arterioscler
Thromb
1991;
11(5):1192–1203.
32. Sadur
CN,
Yost
TJ,
Eckel
RH.
Insulin
responsiveness
of
adipose
tissue
lipoprotein
lipase
is
delayed
but
preserved
in
obesity.
J
Clin
Endocrinol
Metab
1984;
59(6):1176–1182.
33. Hartman
AD.
Lipoprotein
lipase
activities
in
adipose
tissues
and
muscle
in
the
obese
Zucker
rat.
Am
J
Physiol
Endocrinol
Metab
1981;
241(2):E108–E115.
34. Terrettaz
J,
Cusin
I,
Etienne
J,
Jeanrenaud
B.
In
vivo
regulation
of
adipose
tissue
lipoprotein
lipase
in
normal
rats
made
hyperinsulinemic
and
in
hyperinsulinemic
genetically--obese
(fa/fa)
rats.
Int
J
Obes
Relat
Metab
Disord
1994;
18(1):
9–15.
35. Schwartz
RS,
Brunzell
JD.
Increase
of
adipose
tissue
lipoprotein
lipase
activity
with
weight
loss.
J
Clin
Invest
1981;
67(5):1425–1430.
36. Llorente--Cebrián
S,
Kulyté
A,
Hedén
P,
Näslund
E,
Arner
P,
Rydén
M.
Relationship
between
site--specific
HSL
phosphorylation
and
adipocyte
lipolysis
in
obese
women.
Obes
Facts.
2011;
4(5):365--71.
37. Langin
D,
Dicker
A,
Tavernier
G,
Hoffstedt
J,
Mairal
A,
Rydén
M,
Arner
E,
Sicard
A,
Jenkins
CM,
Viguerie
N,
van
Harmelen
V,
Gross
RW,
Holm
C,
Arner
P.
Adipocyte
lipases
and
defect
of
lipolysis
in
human
obesity.
Diabetes.
2005;
54(11):3190--7.
38. Arner
P.
Hunting
for
human
obesity
genes?
Look
in
the
adipose
tissue!
Int
J
Obes
Relat
Metab
Disord.
2000;
24
Suppl
4:S57--62.
39. Valet
P,
Grujic
D,
Wade
J,
Ito
M,
Zingaretti
MC,
Soloveva
V
et
al.
Expression
of
human
alpha
2--adrenergic
receptors
in
adipose
tissue
of
beta
3--adrenergic
receptor--deficient
mice
promotes
diet--induced
obesity.
J
Biol
Chem.
2000;
275(44):34797--802.
341